Powered by: Motilal Oswal
2026-11-16 02:39:34 pm | Source: Emkay Global Financial Services Ltd
Buy Avalon Technologies Ltd for the Target Rs 2,400 by Emkay Global Financial Services Ltd
Buy Avalon Technologies Ltd for the Target Rs 2,400 by Emkay Global Financial Services Ltd

Avalon reported strong 2QFY27 results, beating consensus’ estimates across metrics – operating revenue at +37.4% yoy (consensus: +3.4%), EBITDAM at 12.6% (consensus: 11.8%), and order book at +27% yoy. We view the fundamentals as strong: 1) Robust topline growth without scaled-up contribution from SME, Kavach, or HVDC programs, while weakness in the automotive and medical verticals is likely to reverse going ahead. 2) Management is confident of no “lumpiness” in revenue or front-loading of orders by customers. 3) Implied book-to-bill strengthening to 1.34 (vs 1.05 in 1QFY27; 1.22 in 2QFY26) suggests growth trajectory is intact. 4) Strong EBITDAM performance driven by operating leverage grants room for further improvement, per Management. 5) Strategic benefits from the Zollner JV in the form of new OEM customers and new verticals. 6) Well capitalized balance sheet post warrants issue to Zollner. We believe the story is balanced between strong growth prospects ahead and strong share price performance currently, with shares up ~132% YTD. Avalon has conservatively (as is its usual practice) given guidance “around 30%” topline growth for FY27, implying ~20% yoy growth in 2HFY27 – to not exceed that, Avalon will need deceleration in growth in several verticals which we see as a lower probability scenario. We await more details to emerge on the progress of Avalon’s key new programs and potential revenue from the Zollner JV accruing to Avalon during the JV facility construction phase. We fine-tune and roll forward our estimates to reflect 1HFY27 numbers but keep our DCF-based TP unchanged at Rs2,400 (implying FY28/29E PER of 60x/41x) and reiterate BUY.

Earnings call highlights

1) Revenue guidance raised to 30% from 26-30% earlier, per our expectations.

2) Semicon pipeline healthy – potential to reach 10% of total revenue in the near-to-mid term with just the one customer; additional revenue contingent on other customers.

3) Data center/AI slowdown risk will have no impact on the order book as customers have a good line of sight for the next few years because demand is driven by global diversification of semiconductor capacity.

4) Zollner JV, a strategic accelerator, will bring 2 new verticals—Medical and Test and Measurement equipment, and new European OEM customers.

5) Signed MoU with the TN government for 25 acres of land for future growth, incurring Rs530-540mn capex on the acquisition.

6) Asset turns improved to 10.7x one year ago (oya) and ROCE improved to 24.2% oya.

 

For More  Emkay Global Financial Services Ltd Disclaimer http://www.emkayglobal.com/Uploads/disclaimer.pdf & SEBI Registration number is INH0000003

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here